Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
WuXi AppTec, a Chinese pharmaceutical firm, allegedly transferred a US client's intellectual property to Chinese authorities without consent. Concerns arise over potential criminal charges and implications for the BIOSECURE Act. Reports suggest US intelligence services warned about data sharing with the Chinese government.
Report claims US intelligence services advised the authors of the #BIOSECUREAct that @WuXi_AppTec shared confidential data on US clients with the Chinese government https://t.co/7qMJif9oMo
News about WuXi AppTec stealing IP is very concerning, glad I only work with completely distinct WuXi Biologics! 😊 https://t.co/8Xfrhxdft1
Yiiiiiikes! 🚨 #AAV #GeneTherapy colleagues using @WuXi_AppTec for CRO or CDMO work, assume your IP is compromised. Act accordingly and call counsel, and Congress. https://t.co/fBhtM9KAk1
